Follow us

Experience

Mirnagreen

 in relation to the launch and correct classification of new products based on a disruptive technology for extracting microRNA from plants, including advising on strategy to mitigate risks related to a misclassification under the contiguous categories of medicinal products, novel food and food supplements

Read more

Abbvie Inc.

Advising Abbvie Inc., on the EU merger control aspects of its US$63 billion acquisition of Allergan

Abcam Plc

Advising Abcam on its acquisition of Expedeon AG's proteomics and immunology business for €120m

Genus Plc

Advising Genus, a UK listed animal genetics company, on its strategic partnership with Beijing Capital Agribusiness Co. Ltd (BCA) to research, develop, register and market pigs resistant to Porcine Reproductive and Respiratory Syndrome virus (PRRSv) in China

Impilo

Advising Impilo, a Nordic-based investment company that focuses exclusively on investments in healthcare companies active in the areas of pharmaceuticals, medical technology, healthcare services and other health-related areas, on its leveraged buy-outs of The Fertility Partnership and Viva Neo - leading European providers of fertility services, ultrasound pregnancy scans and hormone treatments

Read more

Lupin Limited

Advising Lupin, on the sale of its entire stake in its Japanese subsidiary, Kyowa Pharmaceutical Industry Co., Ltd. (Kyowa), to Unison Capital for JPY 57.4 billion (c.US$525 million)


Life science notes blog

Find analysis of the latest legal developments relevant to the life sciences

Pharmaceuticals and healthcare

Insight not hindsight

Key contacts

Alan Montgomery photo

Alan Montgomery

Partner, Co-Head Pharmaceuticals, Co-Head of India Practice, London

Alan Montgomery
Chris Parker KC photo

Chris Parker KC

Partner, Co-Head Pharmaceuticals, London

Chris Parker KC
Natalie Bryce photo

Natalie Bryce

Partner, Brisbane

Natalie Bryce